/search, type=deep
Find results for any complex search task
Series b+ biotech companies, with key decision maker, year founded, and recent signalsSearch
Name
Description
URL
Key Decision Maker
Recent Signals
Year Founded
1
Atavistik BioBiotechnology research company founded in 2021; 39 employees (+8.1% YoY growth); $260M total funding including at least one Series C round
atavistkbio.com
Bryan Stuart
Closed $40M Series B extension; total $160M.
2021-01-01
2
eGenesis is a private biotechnology research company specializing in genome engineering and transplantation; with 108 employees
egenesisbio.com
Mike Curtis
Named to Fast Company's Most Innovative Companies 2026
2015-01-01
3
Biotechnology company specializing in oncology biopharmaceuticals; operates as a clinical-stage firm with at least one Series C round
cytomx.com
Sean McCarthy
Pricing $250M Stock Offering
2008-02-01
4
Biotechnology research company founded in 2023; 41 employees (+40.5% YoY growth); $345M total funding including at least one Series B round
attovia.com
Tao Fu
Raised $90M in Series C financing
2023-01-01
5
Private biotechnology research company in Baltimore specializing in immune disorders and cancer treatments; has raised $70.1M
gliknik.com
David Block
Raising funds for autoimmune drug trials
2007-01-01
6
Biotechnology company developing allogeneic gamma-delta T-cell therapies for autoimmune diseases and cancer
adicetbio.com
Chen Schor
Q1 2026 Financial Results Update.
2014-01-01
7
Biotechnology research company specializing in precision ADC therapeutics for solid tumors; raised at least a Series B funding round
sidewinderbio.com
Eric Murphy
Announced $137 Million Series B Financing
2014-01-01
8
BioXell is a publicly traded biotechnology company headquartered in Milan, Italy, with 3 employees and USD 81.2 million in total funding
bioxell.com
Francesco Sinigaglia
Cosmo acquires BioXell S.p.A.
2002-01-01
9
Biotechnology research company specializing in genetic medicines and gene editing; 90 employees; founded 2016; $378.4M total funding
arbor.bio
Devyn Smith
Samsung Life Science Fund Invests in Arbor Biotechnologies
2016-01-01
10
Biotechnology research company specializing in protein-degrading therapeutics; raised at least a Series B funding round
epibiologics.com
Ann Lee-Karlon
First Patient Dosed in Global Phase 1 Study
2022-01-01
Customers
Deep Search used in production at leading companies.
Customers
Deep Search used in production at leading companies.
Extract structured data to power your product
Get results in the exact format you request. Each result is grounded by web citations.
"content": {"companies": [{"company_name": "General Electric","ceo_name": "Larry Culp","founded_year": 1892},{"company_name": "RTX","ceo_name": "Christopher T. Calio","founded_year": 2020},{"company_name": "Boeing","ceo_name": "Kelly Ortberg","founded_year": 1916}]}
Find the latest data for every industry
Query for what matters across company & people data, coding documentation, or whatever your use case requires.
Sample queries
Drug
Sponsor
Approved
Treats
1
Kisunla
Eli Lilly
Jul 2, 2024
Alzheimer's disease
2
Winrevair
Merck
Mar 26, 2024
Pulmonary arterial hypertension
3
Rezdiffra
Madrigal Pharmaceuticals
Mar 14, 2024
Noncirrhotic NASH with fibrosis
4
Voranigo
Servier Pharmaceuticals
Aug 6, 2024
Grade 2 IDH-mutant glioma
5
Cobenfy
Bristol Myers Squibb
Sep 26, 2024
Schizophrenia
6
Journavx
Vertex Pharmaceuticals
Jan 30, 2025
Moderate to severe acute pain
7
Datroway
Daiichi Sankyo
Jan 17, 2025
HR+ HER2- breast cancer
8
Emrelis
AbbVie
May 14, 2025
Non-squamous NSCLC, c-Met overexpression
9
Lynozyfic
Regeneron Pharmaceuticals
Jul 2, 2025
Relapsed or refractory multiple myeloma
10
Idvynso
Merck
Apr 21, 2026
HIV-1 infection (switch regimen)
11
Veppanu
Arvinas
May 1, 2026
ER+ HER2- ESR1-mutated breast cancer
12
Beqalzi
BeOne Medicines
May 13, 2026
Mantle cell lymphoma
13
Baxfendy
AstraZeneca
May 18, 2026
High blood pressure
14
Foundayo
Eli Lilly
Apr 1, 2026
Weight loss in overweight or obese
The highest performance search endpoint at every latency profile
Exa Deep Max94% / 11s
Claude Opus 4.786% / 8s
Gemini 3 Pro90% / 17s
You.com Exhaustive90% / 30s
GPT 5.4 (xhigh)88% / 58s
Perplexity Deep Research68% / 82s
Parallel Ultra88% / 1457s
Accuracy / Latency
FRAMES
Accuracy / Latency
Accuracy (%)
Exa Deep Max94% / 11s
Claude Opus 4.786% / 8s
Gemini 3 Pro90% / 17s
You.com Exhaustive90% / 30s
GPT 5.4 (xhigh)88% / 58s
Perplexity Deep Research68% / 82s
Parallel Ultra88% / 1457s
10s100s1000s
Latency P50 (seconds, log scale)
deep-lite3s
deep6s
deep-reasoning20s